News for Phio Pharmaceuticals Corp Stock (PHIO)

Phio Pharmaceuticals Presents Data at ESMO 2021 Demonstrating Persistent Anti-Tumor Immunity with INTASYL Dual-Targeting PD-1 and BRD4

PRNewsWire • 09/16/21

Phio Pharmaceuticals to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference September 13th-15th

PRNewsWire • 09/03/21

Phio Pharmaceuticals Announces Upcoming Data Presentation at the ESMO Virtual Congress 2021

PRNewsWire • 08/31/21

Phio Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update

PRNewsWire • 08/12/21

Phio Pharmaceuticals Scheduled to Participate in a Fireside Chat with H.C. Wainwright on July 12th

PRNewsWire • 07/07/21

Phio Pharmaceuticals Reschedules Fireside Chat Hosted by H.C. Wainwright for July 12th

PRNewsWire • 06/22/21

Phio Pharmaceuticals Scheduled to Participate in Two Upcoming Investor Events in June

PRNewsWire • 06/14/21

Phio Pharmaceuticals Presents New In Vivo Data at the 2021 ASCO Annual Meeting Showing Dual-Targeting INTASYL Offers Increased Efficacy and Safety Potential Over Other Therapeutic Approaches

PRNewsWire • 06/04/21

Phio Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update

PRNewsWire • 05/13/21

Phio Pharma's PH-762 Shows Encouraging Antitumor Efficacy In Preclinical Studies

Benzinga • 05/11/21

Phio Pharmaceuticals Presents Positive In Vivo Data at ASGCT Showing PH-762 Significantly Enhanced Antitumor Efficacy of HER2-Targeted CAR-T Cells

PRNewsWire • 05/11/21

4 Hot Reddit Penny Stocks With Higher Than Average Volume

PennyStocks • 05/07/21

Phio Pharmaceuticals Announces Upcoming Data Presentations at the ASGCT and ASCO Annual Meetings

PRNewsWire • 04/29/21

Phio Pharma's Intasyl Platform Shows Promising Tumor Control Activity In Animal Studies

Benzinga • 04/12/21

Phio Pharmaceuticals Presents Positive In Vivo Data Showing Strong Tumor Control for the Intratumoral Delivery of INTASYL™ RNAi Targeting PD-1

PRNewsWire • 04/10/21

Phio Pharmaceuticals Reports 2020 Year End Financial Results and Provides Business Update

PRNewsWire • 03/25/21

PHIO Stock Price Increases Over 10% Pre-Market: Why It Happened

Pulse2 • 03/11/21

Phio Pharmaceuticals To Present New Data on PD-1 Targeting INTASYL at the 2021 American Association for Cancer Research (AACR) Annual Meeting

PRNewsWire • 03/11/21

Phio Pharma Shares Are Trading Higher On Cancer Immunotherapies Pact With AgonOx

Benzinga • 03/01/21

Phio Pharmaceuticals to Participate in the H.C. Wainwright Global Life Sciences Conference on March 9th-10th

PRNewsWire • 02/23/21

Phio Pharmaceuticals Announces Closing of $7.7 Million Registered Direct Offering of Common Stock Priced At-the-Market

PRNewsWire • 02/17/21

Phio Pharmaceuticals Announces Closing of $14.0 Million Private Placement Priced At-the-Market

PRNewsWire • 01/25/21

Phio Pharmaceuticals Announces $14.0 Million Private Placement Priced At-the-Market

PRNewsWire • 01/21/21

Phio Pharmaceuticals to Participate in the H.C. Wainwright BioConnect 2021 Conference

PRNewsWire • 01/04/21

Phio Pharmaceuticals to Participate in the 3rd Annual Evercore ISI HealthCONx Conference

PRNewsWire • 11/19/20